Management implications associated with switching from vitamin K antagonist anticoagulants to direct oral anticoagulants

被引：0
|
作者：
Pia-Morandeira, Agustin [1 ]
Cinza-Sanjurjo, Sergio [2 ,3 ,4 ]
Portela-Romero, Manuel [4 ,5 ]
机构：
[1] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Noia, La Coruna, Spain
[2] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Porto Son, La Coruna, Spain
[3] Inst Invest Sanitaria Santiago Compostela IDIS, La Coruna, Spain
[4] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain
[5] Area Sanitaria Integrada Santiago Compostela, Ctr Saude Concepcion Arenal, La Coruna, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2022年 / 75卷 / 04期
关键词：
D O I：
10.1016/j.rec.2021.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：345 / 347
页数：3
相关论文
共 50 条
  • [1] Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus
    Iqbal, Hansa
    Straw, Sam
    Craven, Thomas P.
    Stirling, Katherine
    Wheatcroft, Stephen B.
    Witte, Klaus K.
    ESC HEART FAILURE, 2020, 7 (05): : 2032 - 2041
  • [2] Direct oral anticoagulants compared to vitamin-K antagonist for the management of left ventricular thrombus
    Straw, S. Sam
    Iqbal, H.
    Craven, T.
    Stirling, K.
    Wheatcroft, S.
    Witte, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 51 - 51
  • [3] Management of Non-Vitamin K Antagonist Oral Anticoagulants in the Perioperative Setting
    Dincq, Anne-Sophie
    Lessire, Sarah
    Douxfils, Jonathan
    Dogne, Jean-Michel
    Gourdin, Maximilien
    Mullier, Francois
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns
    Toorop, Myrthe M. A.
    van Rein, Nienke
    Nierman, Melchior C.
    Vermaas, Helga W.
    Huisman, Menno V.
    van der Meer, Felix J. M.
    Cannegieter, Suzanne C.
    Lijfering, Willem M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (06) : 1390 - 1397
  • [5] Oral vitamin K in the management of oral anticoagulants overdose
    Morelli, VM
    Lourenço, DM
    Vignal, CV
    THROMBOSIS AND HAEMOSTASIS, 1999, : 678 - 678
  • [6] The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation
    Vinding, Naja Emborg
    Bonde, Anders Nissen
    Rorth, Rasmus
    Lamberts, Morten
    Olesen, Jonas Bjerring
    Gislason, Gunnar Hilmar
    Torp-Pedersen, Christian
    Kober, Lars
    Fosbol, Emit Loldrup
    EUROPACE, 2019, 21 (04): : 572 - 579
  • [7] MANAGEMENT OF BLEEDING ASSOCIATED WITH VITAMIN-K ANTAGONISTS (VKA) AND DIRECT ORAL ANTICOAGULANTS (DOAC)
    Marietta, M.
    Coluccio, V.
    Paolini, A.
    Luppi, M.
    HAEMATOLOGICA, 2017, 102 : 190 - 192
  • [8] Non-vitamin K antagonist oral anticoagulants and sport
    Romano, Silvio
    Salustri, Elisa
    Robles, Antonio G.
    Calo, Leonardo
    Penco, Maria
    Sciarra, Luigi
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (02): : 98 - 109
  • [9] Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism
    Blann, Andrew D.
    Lip, Gregory Y. H.
    HEART, 2016, 102 (12) : 975 - 983
  • [10] Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants
    Faraoni, David
    Levy, Jerrold H.
    Albaladejo, Pierre
    Samama, Charles-Marc
    CRITICAL CARE, 2015, 19
12345